Table of Content

1 Market Overview of Gene Therapy Drugs
1.1 Gene Therapy Drugs Market Overview
1.1.1 Gene Therapy Drugs Product Scope
1.1.2 Gene Therapy Drugs Market Status and Outlook
1.2 Global Gene Therapy Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Gene Therapy Drugs Market Size by Region (2024-2034)
1.4 Global Gene Therapy Drugs Historic Market Size by Region (2024-2024)
1.5 Global Gene Therapy Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Gene Therapy Drugs Market Size (2024-2034)
1.6.1 North America Gene Therapy Drugs Market Size (2024-2034)
1.6.2 Europe Gene Therapy Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Gene Therapy Drugs Market Size (2024-2034)
1.6.4 Latin America Gene Therapy Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Gene Therapy Drugs Market Size (2024-2034)
2 Gene Therapy Drugs Market by Type
2.1 Introduction
2.1.1 Neuromuscular Disease
2.1.2 Genetic Disease
2.1.3 Other
2.2 Global Gene Therapy Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Gene Therapy Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Therapy Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Gene Therapy Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Gene Therapy Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Gene Therapy Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Gene Therapy Drugs Revenue Breakdown by Type (2024-2034)
3 Gene Therapy Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharmacy
3.2 Global Gene Therapy Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Gene Therapy Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Therapy Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Gene Therapy Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Gene Therapy Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Gene Therapy Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Gene Therapy Drugs Revenue Breakdown by Application (2024-2034)
4 Gene Therapy Drugs Competition Analysis by Players
4.1 Global Gene Therapy Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
4.3 Date of Key Players Enter into Gene Therapy Drugs Market
4.4 Global Top Players Gene Therapy Drugs Headquarters and Area Served
4.5 Key Players Gene Therapy Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche AG
5.1.1 F. Hoffmann-La Roche AG Profile
5.1.2 F. Hoffmann-La Roche AG Main Business
5.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 F. Hoffmann-La Roche AG Recent Developments
5.2 Novartis International AG
5.2.1 Novartis International AG Profile
5.2.2 Novartis International AG Main Business
5.2.3 Novartis International AG Gene Therapy Drugs Products, Services and Solutions
5.2.4 Novartis International AG Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 Novartis International AG Recent Developments
5.3 Gilead Sciences, Inc.
5.3.1 Gilead Sciences, Inc. Profile
5.3.2 Gilead Sciences, Inc. Main Business
5.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Products, Services and Solutions
5.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Ultragenyx Pharmaceutical，Inc. Recent Developments
5.4 Ultragenyx Pharmaceutical，Inc.
5.4.1 Ultragenyx Pharmaceutical，Inc. Profile
5.4.2 Ultragenyx Pharmaceutical，Inc. Main Business
5.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Products, Services and Solutions
5.4.4 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments
5.5 Applied Genetic Technologies Corp
5.5.1 Applied Genetic Technologies Corp Profile
5.5.2 Applied Genetic Technologies Corp Main Business
5.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Products, Services and Solutions
5.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 Applied Genetic Technologies Corp Recent Developments
5.6 Audentes Therapeutics
5.6.1 Audentes Therapeutics Profile
5.6.2 Audentes Therapeutics Main Business
5.6.3 Audentes Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.6.5 Audentes Therapeutics Recent Developments
5.7 BioMarin Pharmaceutical
5.7.1 BioMarin Pharmaceutical Profile
5.7.2 BioMarin Pharmaceutical Main Business
5.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Products, Services and Solutions
5.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.7.5 BioMarin Pharmaceutical Recent Developments
5.8 Bluebird Bio
5.8.1 Bluebird Bio Profile
5.8.2 Bluebird Bio Main Business
5.8.3 Bluebird Bio Gene Therapy Drugs Products, Services and Solutions
5.8.4 Bluebird Bio Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.8.5 Bluebird Bio Recent Developments
5.9 Nightstar Therapeutics
5.9.1 Nightstar Therapeutics Profile
5.9.2 Nightstar Therapeutics Main Business
5.9.3 Nightstar Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.9.5 Nightstar Therapeutics Recent Developments
5.10 Sangamo Therapeutics
5.10.1 Sangamo Therapeutics Profile
5.10.2 Sangamo Therapeutics Main Business
5.10.3 Sangamo Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.10.5 Sangamo Therapeutics Recent Developments
5.11 Spark Therapeutics
5.11.1 Spark Therapeutics Profile
5.11.2 Spark Therapeutics Main Business
5.11.3 Spark Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.11.4 Spark Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.11.5 Spark Therapeutics Recent Developments
5.12 uniQure
5.12.1 uniQure Profile
5.12.2 uniQure Main Business
5.12.3 uniQure Gene Therapy Drugs Products, Services and Solutions
5.12.4 uniQure Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.12.5 uniQure Recent Developments
5.13 VBL Therapeutics
5.13.1 VBL Therapeutics Profile
5.13.2 VBL Therapeutics Main Business
5.13.3 VBL Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.13.4 VBL Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.13.5 VBL Therapeutics Recent Developments
5.14 Voyager Therapeutics
5.14.1 Voyager Therapeutics Profile
5.14.2 Voyager Therapeutics Main Business
5.14.3 Voyager Therapeutics Gene Therapy Drugs Products, Services and Solutions
5.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue (US$ Million) & (2024-2024)
5.14.5 Voyager Therapeutics Recent Developments
6 North America
6.1 North America Gene Therapy Drugs Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Therapy Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Therapy Drugs Market Dynamics
11.1 Gene Therapy Drugs Industry Trends
11.2 Gene Therapy Drugs Market Drivers
11.3 Gene Therapy Drugs Market Challenges
11.4 Gene Therapy Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Gene Therapy Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Gene Therapy Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Gene Therapy Drugs Market Size Share by Region (2024-2024)
Table 4. Global Gene Therapy Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Gene Therapy Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Gene Therapy Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Gene Therapy Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Gene Therapy Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Gene Therapy Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Gene Therapy Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Gene Therapy Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Gene Therapy Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Gene Therapy Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Gene Therapy Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Gene Therapy Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Gene Therapy Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Gene Therapy Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Gene Therapy Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Gene Therapy Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Gene Therapy Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Gene Therapy Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Gene Therapy Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Gene Therapy Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Gene Therapy Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Gene Therapy Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Gene Therapy Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Gene Therapy Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2022)
Table 39. Date of Key Players Enter into Gene Therapy Drugs Market
Table 40. Global Gene Therapy Drugs Key Players Headquarters and Area Served
Table 41. Gene Therapy Drugs Product Solution and Service
Table 42. Global Gene Therapy Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. F. Hoffmann-La Roche AG Basic Information List
Table 45. F. Hoffmann-La Roche AG Description and Business Overview
Table 46. F. Hoffmann-La Roche AG Gene Therapy Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Gene Therapy Drugs Business of F. Hoffmann-La Roche AG (2024-2024)
Table 48. F. Hoffmann-La Roche AG Recent Developments
Table 49. Novartis International AG Basic Information List
Table 50. Novartis International AG Description and Business Overview
Table 51. Novartis International AG Gene Therapy Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Gene Therapy Drugs Business of Novartis International AG (2024-2024)
Table 53. Novartis International AG Recent Developments
Table 54. Gilead Sciences, Inc. Basic Information List
Table 55. Gilead Sciences, Inc. Description and Business Overview
Table 56. Gilead Sciences, Inc. Gene Therapy Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Gene Therapy Drugs Business of Gilead Sciences, Inc. (2024-2024)
Table 58. Gilead Sciences, Inc. Recent Developments
Table 59. Ultragenyx Pharmaceutical，Inc. Basic Information List
Table 60. Ultragenyx Pharmaceutical，Inc. Description and Business Overview
Table 61. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Gene Therapy Drugs Business of Ultragenyx Pharmaceutical，Inc. (2024-2024)
Table 63. Ultragenyx Pharmaceutical，Inc. Recent Developments
Table 64. Applied Genetic Technologies Corp Basic Information List
Table 65. Applied Genetic Technologies Corp Description and Business Overview
Table 66. Applied Genetic Technologies Corp Gene Therapy Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Gene Therapy Drugs Business of Applied Genetic Technologies Corp (2024-2024)
Table 68. Applied Genetic Technologies Corp Recent Developments
Table 69. Audentes Therapeutics Basic Information List
Table 70. Audentes Therapeutics Description and Business Overview
Table 71. Audentes Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Gene Therapy Drugs Business of Audentes Therapeutics (2024-2024)
Table 73. Audentes Therapeutics Recent Developments
Table 74. BioMarin Pharmaceutical Basic Information List
Table 75. BioMarin Pharmaceutical Description and Business Overview
Table 76. BioMarin Pharmaceutical Gene Therapy Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Gene Therapy Drugs Business of BioMarin Pharmaceutical (2024-2024)
Table 78. BioMarin Pharmaceutical Recent Developments
Table 79. Bluebird Bio Basic Information List
Table 80. Bluebird Bio Description and Business Overview
Table 81. Bluebird Bio Gene Therapy Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Gene Therapy Drugs Business of Bluebird Bio (2024-2024)
Table 83. Bluebird Bio Recent Developments
Table 84. Nightstar Therapeutics Basic Information List
Table 85. Nightstar Therapeutics Description and Business Overview
Table 86. Nightstar Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Gene Therapy Drugs Business of Nightstar Therapeutics (2024-2024)
Table 88. Nightstar Therapeutics Recent Developments
Table 89. Sangamo Therapeutics Basic Information List
Table 90. Sangamo Therapeutics Description and Business Overview
Table 91. Sangamo Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Gene Therapy Drugs Business of Sangamo Therapeutics (2024-2024)
Table 93. Sangamo Therapeutics Recent Developments
Table 94. Spark Therapeutics Basic Information List
Table 95. Spark Therapeutics Description and Business Overview
Table 96. Spark Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Gene Therapy Drugs Business of Spark Therapeutics (2024-2024)
Table 98. Spark Therapeutics Recent Developments
Table 99. uniQure Basic Information List
Table 100. uniQure Description and Business Overview
Table 101. uniQure Gene Therapy Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Gene Therapy Drugs Business of uniQure (2024-2024)
Table 103. uniQure Recent Developments
Table 104. VBL Therapeutics Basic Information List
Table 105. VBL Therapeutics Description and Business Overview
Table 106. VBL Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Gene Therapy Drugs Business of VBL Therapeutics (2024-2024)
Table 108. VBL Therapeutics Recent Developments
Table 109. Voyager Therapeutics Basic Information List
Table 110. Voyager Therapeutics Description and Business Overview
Table 111. Voyager Therapeutics Gene Therapy Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Gene Therapy Drugs Business of Voyager Therapeutics (2024-2024)
Table 113. Voyager Therapeutics Recent Developments
Table 114. North America Gene Therapy Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 115. North America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 116. Europe Gene Therapy Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 117. Europe Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 118. Asia-Pacific Gene Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Asia-Pacific Gene Therapy Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 120. Asia-Pacific Gene Therapy Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 121. Asia-Pacific Gene Therapy Drugs Market Share by Region (2024-2024)
Table 122. Asia-Pacific Gene Therapy Drugs Market Share by Region (2024-2034)
Table 123. Latin America Gene Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Latin America Gene Therapy Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 125. Latin America Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 126. Middle East & Africa Gene Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 127. Middle East & Africa Gene Therapy Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 128. Middle East & Africa Gene Therapy Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 129. Gene Therapy Drugs Market Trends
Table 130. Gene Therapy Drugs Market Drivers
Table 131. Gene Therapy Drugs Market Challenges
Table 132. Gene Therapy Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Gene Therapy Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Gene Therapy Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Gene Therapy Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Gene Therapy Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Gene Therapy Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Gene Therapy Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Gene Therapy Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Gene Therapy Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Neuromuscular Disease
Figure 11. Global Neuromuscular Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Genetic Disease
Figure 13. Global Genetic Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Gene Therapy Drugs Market Size Share by Type: 2022 & 2034
Figure 17. North America Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Figure 18. Europe Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Type (2024-2034)
Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Pharmacy Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Gene Therapy Drugs Market Size Share by Application: 2022 & 2034
Figure 25. North America Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Figure 26. Europe Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Application (2024-2034)
Figure 30. Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Gene Therapy Drugs Market Share in 2022
Figure 32. North America Gene Therapy Drugs Market Share by Country (2024-2034)
Figure 33. United States Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 36. France Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Gene Therapy Drugs Market Share by Region (2024-2034)
Figure 42. China Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 46. India Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Gene Therapy Drugs Market Share by Country (2024-2034)
Figure 49. Mexico Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Gene Therapy Drugs Market Share by Country (2024-2034)
Figure 52. Turkey Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Gene Therapy Drugs Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report